Open original FDA record ↗Recall record
- FDA identifier
- Z-0021-2018
- Company in FDA record
- OriGen Biomedical, Inc.
- FDA classification date
- Oct 20, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Two users have reported to OriGen that a VV28F OriGen Reinforced Dual Lumen ECMO Catheter has had a separation of the clear extension tube from the hub connection. These adverse events resulted in patient injury (blood loss).
Source facts
- Action
- The firm initiated their recall by letter on 08/02/2017, following with a press release on 08/28/2017. The firm sent a revised letter to include instructions for the distributors on 09/22/2017 and an updated press release was sent on 09/26/2017. The firm requested that the consignee discontinue use of all OriGen VV28F Reinforced Dual Lumen ECMO Catheters from lots N18487 and N18487-1 and return any of those lots to OriGen Biomedical immediately for replacement or product credit.
- Initiated
- 2017-08-02
- Root cause
- Under Investigation by firm
- Terminated
- 2024-02-29
- Distribution
- US Nationwide and the countries of Austria, Belgium, Chile, Czech Republic, Italy, Kingdom of Saudi Arabia, Netherlands, Poland, Sweden, Thailand, Colombia, India, South Africa, United Arab Emirates.
- Recall number
- Z-0021-2018
- Recall status
- Terminated
- CDRH record ID
- 158533
- FDA classified
- 2017-10-20
- Recall event number
- 78033